- Home
- BMRN vs AVY Comparison
BMRN vs AVY Comparison
Compare BMRN & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- AVY
- Stock Information
- Founded
- BMRN 1996
- AVY 1935
- Country
- BMRN United States
- AVY United States
- Employees
- BMRN N/A
- AVY N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- AVY Containers/Packaging
- Sector
- BMRN Health Care
- AVY Consumer Discretionary
- Exchange
- BMRN Nasdaq
- AVY Nasdaq
- Market Cap
- BMRN 12.1B
- AVY 14.4B
- IPO Year
- BMRN 1999
- AVY N/A
- Fundamental
- Price
- BMRN $59.01
- AVY $177.82
- Analyst Decision
- BMRN Buy
- AVY Buy
- Analyst Count
- BMRN 23
- AVY 10
- Target Price
- BMRN $93.73
- AVY $197.00
- AVG Volume (30 Days)
- BMRN 1.8M
- AVY 715.6K
- Earning Date
- BMRN 08-04-2025
- AVY 07-22-2025
- Dividend Yield
- BMRN N/A
- AVY 2.11%
- EPS Growth
- BMRN 152.82
- AVY 14.63
- EPS
- BMRN 2.71
- AVY 8.92
- Revenue
- BMRN $2,950,227,000.00
- AVY $8,737,900,000.00
- Revenue This Year
- BMRN $12.27
- AVY $2.36
- Revenue Next Year
- BMRN $9.99
- AVY $4.11
- P/E Ratio
- BMRN $21.81
- AVY $20.01
- Revenue Growth
- BMRN 19.36
- AVY 1.66
- 52 Week Low
- BMRN $52.93
- AVY $157.00
- 52 Week High
- BMRN $94.85
- AVY $224.38
- Technical
- Relative Strength Index (RSI)
- BMRN 55.66
- AVY 46.71
- Support Level
- BMRN $56.48
- AVY $168.78
- Resistance Level
- BMRN $60.43
- AVY $184.44
- Average True Range (ATR)
- BMRN 1.52
- AVY 3.89
- MACD
- BMRN 0.23
- AVY -0.37
- Stochastic Oscillator
- BMRN 64.05
- AVY 50.79
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.